A mechanistic study on the cardiotoxicity of 5-fluorouracil in vitro and clinical and occupational perspectives-Reference-Cited by-同舟云学术

A mechanistic study on the cardiotoxicity of 5-fluorouracil in vitro and clinical and occupational perspectives

Published:2014-06 Issue:3 Volume:227 Page:151-156
ISSN:0378-4274
Container-title:Toxicology Letters
language:en
Short-container-title:Toxicology Letters

Author:

Lamberti Monica,Porto Stefania,Zappavigna Silvia,Addeo Erasmo,Marra Monica,Miraglia Nadia,Sannolo Nicola,Vanacore Daniela,Stiuso Paola,Caraglia Michele

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference42 articles.

1. Adjuvant chemotherapy in curative resected colon carcinoma: 5-fluorouracil/leucovorin versus high-dose 5-fluorouracil 24-h infusion/leucovorin versus high-dose 5-fluorouracil 24h infusion;Arkenau;Int. J. Colorectal Dis.,2005

2. Adjuvant treatment for gastric cancer: chemotherapy versus radiation;Ashraf;Oncologist,2013

3. Supraventricular arrhythmia: a complication of 5-fluorouracil therapy;Aziz;Clin. Oncol.,1998

4. Chemotherapy and cardiotoxicity;Brestescher;Ann. Cardiol. Angeiol.,1995

5. LC–MS/MS method for simultaneous analysis of uracil, 5,6-dihydrouracil, 5-fluorouracil and 5-fluoro-5,6-dihydrouracil in human plasma for therapeutic drug monitoring and toxicity prediction in cancer patients;Büchel;Biomed. Chromatogr.,2013

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms, Clinical Management and Innovative Treatment;Drug Design, Development and Therapy;2024-09

2. Cardiotoxic Drugs: An Insight into its Pathologic Mechanisms;Biosciences Biotechnology Research Asia;2024-03-30

3. A review of chemotherapeutic drugs-induced arrhythmia and potential intervention with traditional Chinese medicines;Frontiers in Pharmacology;2024-03-20

4. Identifying metabolic adaptations characteristic of cardiotoxicity using paired transcriptomics and metabolomics data integrated with a computational model of heart metabolism;PLOS Computational Biology;2024-02-29

5. Management of Fluoropyrimidine-Induced Cardiac Adverse Outcomes Following Cancer Treatment;Cardiovascular Toxicology;2024-02